These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38788675)

  • 1. Alzheimer disease-related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study.
    Mandelblatt J; Dage JL; Zhou X; Small BJ; Ahles TA; Ahn J; Artese A; Bethea TN; Breen EC; Carroll JE; Cohen HJ; Extermann M; Graham D; Claudine I; Jim HSL; McDonald BC; Nakamura ZM; Patel SK; Rebeck GW; Rentscher KE; Root JC; Russ KA; Tometich DB; Turner RS; Van Dyk K; Zhai W; Huang LW; Saykin AJ
    J Natl Cancer Inst; 2024 Sep; 116(9):1495-1507. PubMed ID: 38788675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.
    Zhang Y; Ferreira PCL; Jacobsen E; Bellaver B; Pascoal TA; Snitz BE; Chang CH; Villemagne VL; Ganguli M; Karikari TK
    Alzheimers Dement; 2024 Jun; 20(6):4199-4211. PubMed ID: 38753951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression.
    Rabl M; Zullo L; Lewczuk P; Kornhuber J; Karikari TK; Blennow K; Zetterberg H; Bavato F; Quednow BB; Seifritz E; von Gunten A; Clark C; Popp J
    Alzheimers Res Ther; 2024 Jul; 16(1):165. PubMed ID: 39054505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.
    Park MK; Ahn J; Kim YJ; Lee JW; Lee JC; Hwang SJ; Kim KC
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
    Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
    Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
    Bolsewig K; van Unnik AAJM; Blujdea ER; Gonzalez MC; Ashton NJ; Aarsland D; Zetterberg H; Padovani A; Bonanni L; Mollenhauer B; Schade S; Vandenberghe R; Poesen K; Kramberger MG; Paquet C; Bousiges O; Cretin B; Willemse EAJ; Teunissen CE; Lemstra AW;
    Neurology; 2024 Jun; 102(12):e209418. PubMed ID: 38830138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
    Cousins KAQ; Phillips JS; Das SR; O'Brien K; Tropea TF; Chen-Plotkin A; Shaw LM; Nasrallah IM; Mechanic-Hamilton D; McMillan CT; Irwin DJ; Lee EB; Wolk DA
    Alzheimers Dement; 2024 Jun; 20(6):3889-3905. PubMed ID: 38644682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline.
    Wei YC; Kung YC; Lin C; Yeh CH; Chen PY; Huang WY; Shyu YC; Lin CP; Chen CK
    Transl Psychiatry; 2024 Aug; 14(1):333. PubMed ID: 39152102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study.
    Rajan KB; Aggarwal NT; McAninch EA; Weuve J; Barnes LL; Wilson RS; DeCarli C; Evans DA
    Ann Neurol; 2020 Dec; 88(6):1065-1076. PubMed ID: 32799383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients.
    Mendes AJ; Ribaldi F; Lathuiliere A; Ashton NJ; Zetterberg H; Abramowicz M; Scheffler M; Assal F; Garibotto V; Blennow K; Frisoni GB
    Alzheimers Res Ther; 2024 May; 16(1):110. PubMed ID: 38755703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
    Sperling RA; Donohue MC; Rissman RA; Johnson KA; Rentz DM; Grill JD; Heidebrink JL; Jenkins C; Jimenez-Maggiora G; Langford O; Liu A; Raman R; Yaari R; Holdridge KC; Sims JR; Aisen PS
    J Prev Alzheimers Dis; 2024; 11(4):802-813. PubMed ID: 39044488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived Stress, Blood Biomarkers, and Cognitive Functioning in Older Adults.
    Desai P; Ng TKS; Krueger KR; Wilson RS; Evans DA; Rajan KB
    Psychosom Med; 2024 Jul-Aug 01; 86(6):507-511. PubMed ID: 38648023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.
    Lu Y; Pike JR; Chen J; Walker KA; Sullivan KJ; Thyagarajan B; Mielke MM; Lutsey PL; Knopman D; Gottesman RF; Sharrett AR; Coresh J; Mosley TH; Palta P
    JAMA; 2024 Oct; 332(15):1258-1269. PubMed ID: 39068543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment.
    Zhao L; Qiu Q; Zhang S; Yan F; Li X
    Exp Gerontol; 2024 Oct; 195():112535. PubMed ID: 39128687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of
    Van Dyk K; Zhou X; Small BJ; Ahn J; Zhai W; Ahles T; Graham D; Jacobsen PB; Jim H; McDonald BC; Nudelman Holohan K; Patel SK; Rebeck GW; Root JC; Saykin AJ; Cohen HJ; Mandelblatt JS; Carroll JE
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33748669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.
    Ingannato A; Bagnoli S; Mazzeo S; Giacomucci G; Bessi V; Ferrari C; Sorbi S; Nacmias B
    Front Endocrinol (Lausanne); 2024; 15():1375302. PubMed ID: 38654932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease.
    Warmenhoven N; Sánchez-Benavides G; González-Escalante A; Milà-Alomà M; Shekari M; López-Martos D; Ortiz-Romero P; Kollmorgen G; Quijano-Rubio C; Minguillón C; Gispert JD; Vilor-Tejedor N; Arenaza-Urquijo E; Palpatzis E; Ashton NJ; Zetterberg H; Blennow K; Suárez-Calvet M; Grau-Rivera O;
    Alzheimers Dement; 2024 Sep; 20(9):5819-5832. PubMed ID: 39032119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study.
    Götze K; Vrillon A; Dumurgier J; Indart S; Sanchez-Ortiz M; Slimi H; Raynaud-Simon A; Cognat E; Martinet M; Zetterberg H; Blennow K; Hourrègue C; Bouaziz-Amar E; Paquet C; Lilamand M
    Alzheimers Res Ther; 2024 Oct; 16(1):231. PubMed ID: 39427171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.